Aortic Aneurysm

Aortic aneurysm care encompasses screening, diagnostic imaging, surveillance, medical risk reduction, open repair, and endovascular intervention. Clinical priorities center on identifying aneurysms before rupture, assessing anatomy and growth, controlling cardiovascular risk, and matching intervention timing and technique to patient-specific risk. Outcomes depend not only on procedural capability but also on referral pathways, longitudinal follow-up, emergency readiness, and access to specialist vascular services.

The landscape is shifting from predominantly emergency treatment toward risk-based surveillance and planned intervention. Improvements in ultrasound, computed tomography, magnetic resonance imaging, image fusion, and three-dimensional planning support more consistent anatomical assessment. Endovascular approaches can reduce procedural burden for selected patients, while open surgery remains important for complex anatomy, younger patients, and situations where durable repair or emergency control is required.

Care delivery is also becoming more integrated. Multidisciplinary teams increasingly combine vascular surgery, cardiology, radiology, anesthesiology, genetics, and primary care. Persistent challenges include delayed presentation, inconsistent screening, limited specialist access, device suitability constraints, post-intervention surveillance, and the need to manage patients whose anatomy or comorbidities complicate standard treatment pathways.

Artificial intelligence can support aortic aneurysm care by identifying abnormal aortic dimensions on imaging, prioritizing examinations for review, segmenting vessels, and measuring changes across serial studies. These capabilities may help reduce overlooked findings and improve consistency, particularly in high-volume imaging environments.

AI-assisted planning may also aid centerline analysis, anatomical characterization, device selection, and procedural simulation. In follow-up, automated comparison of prior scans could flag meaningful growth or changes requiring specialist review. Adoption requires clinically validated performance across diverse populations, transparent outputs, integration with imaging workflows, cybersecurity safeguards, and clear accountability for clinician decisions. AI should augment-not replace-expert interpretation and shared decision-making.

North America generally emphasizes organized vascular referral, advanced imaging, endovascular capability, and longitudinal surveillance, while access and affordability remain uneven across communities. Europe combines established specialist networks with national differences in screening policy, referral speed, reimbursement, and access to complex intervention.

Asia-Pacific spans highly advanced urban systems and settings where imaging, specialist capacity, and emergency transport remain constrained. Latin America faces variation in diagnostic access, surgical infrastructure, and continuity of follow-up, increasing the importance of regional referral networks. In the Middle East, concentrated specialist capacity in major centers coexists with geographic access challenges and differing national pathways. Africa requires stronger diagnostic availability, referral coordination, trained personnel, and emergency surgical capacity, alongside prevention and cardiovascular-risk programs suited to local needs.

ASEAN countries show wide variation in screening access, imaging capacity, specialist density, and urban–rural continuity of care, making shared training and referral standards valuable. BRICS members similarly span substantial differences in population scale, infrastructure, and specialist access, with opportunities to strengthen earlier diagnosis and standardized surveillance.

The European Union benefits from cross-border clinical knowledge exchange but continues to manage differences in national guidelines, reimbursement, and service organization. G7 systems generally have strong specialist capabilities while facing aging populations, workforce pressure, and the need to improve equitable access. GCC systems often combine advanced tertiary centers with high demand for coordinated referral and follow-up. NATO countries encompass diverse health systems, but common interests include trauma readiness, interoperable clinical practices, and resilient access to essential imaging and vascular services.

Australia combines advanced tertiary vascular services with the challenge of serving dispersed populations. Brazil and Mexico face regional variation in imaging, referral pathways, and access to specialist intervention. Canada and the United States have substantial procedural expertise, but rural access, affordability, and continuity of surveillance remain important considerations.

China and India are expanding advanced diagnostic and interventional capacity while managing considerable geographic and health-system diversity. Japan, South Korea, France, Germany, Italy, Spain, and the United Kingdom have established specialist services, with ongoing priorities involving aging populations, pathway efficiency, workforce capacity, and consistent follow-up. Russia’s care environment reflects geographic scale and uneven access between major centers and more remote regions. Across all countries, timely diagnosis, standardized measurement, cardiovascular-risk management, and reliable post-treatment surveillance remain central to better outcomes.

Industry and health-system leaders should prioritize coordinated pathways linking primary care, diagnostic imaging, vascular specialists, emergency services, and rehabilitation. Practical actions include defining referral thresholds, strengthening ultrasound and cross-sectional imaging quality, reducing delays in specialist review, and establishing registries that track surveillance adherence, intervention outcomes, complications, and reintervention.

Technology investments should focus on interoperable imaging systems, validated decision-support tools, remote consultation, and structured reporting. Organizations should pair innovation with clinician training, patient education, equitable access programs, and robust cybersecurity. Procurement and service planning should account for total care requirements, including anatomical suitability, operator expertise, emergency coverage, device follow-up, and long-term imaging-not only the procedure itself.

This executive summary is based on a structured synthesis of established clinical concepts relating to aortic aneurysm detection, surveillance, risk-factor management, imaging, open repair, endovascular treatment, multidisciplinary care, and health-system access. Insights are organized across regional, country, and multinational group perspectives to identify recurring operational and clinical priorities.

The approach emphasizes qualitative interpretation rather than numerical market measurement. It considers differences in infrastructure, specialist availability, referral organization, diagnostic capability, treatment complexity, and continuity of follow-up. Because policies and clinical practices vary by jurisdiction, conclusions should be interpreted alongside current local guidelines, regulatory requirements, epidemiological evidence, and institutional outcomes data.

Aortic aneurysm management is evolving through improved imaging, more selective use of minimally invasive repair, stronger multidisciplinary coordination, and growing interest in AI-supported workflows. The most meaningful gains will come from connecting these advances to dependable screening or case-finding, timely referral, individualized risk assessment, and sustained surveillance.

Regional and country differences make adaptable implementation essential. Leaders who combine clinical quality, equitable access, data governance, workforce development, emergency preparedness, and patient-centered follow-up will be better positioned to reduce preventable rupture and improve the consistency and durability of care.